Related Experiment Videos
Xpa knockout mice
1Department of Carcinogenesis, Mutagenesis and Genetics, National Institute of Public Health and Environment, Bilthoven, The Netherlands.
Abstract:
The xeroderma pigmentosum group A correcting (XPA) gene encodes a DNA binding zinc-finger protein that recognizes DNA damage. As such the XPA protein participates in the initial step of the process of nucleotide excision repair. The multicomponent nucleotide excision repair pathway is one of the most thoroughly studied mechanisms that defends both eukaryotic and prokaryotic cells against the deleterious effects of UV-B and several chemical components. In the absence of nucleotide excision repair common cellular processes like transcription and replication are disturbed by persisting (unrepaired) DNA lesions (adducts), which may lead to the accumulation of gene mutations and ultimately to cancer. Xeroderma pigmentosum patients have a > 2000 fold increased risk to develop skin cancer at sun-exposed areas. Here we describe that XPA-deficient transgenic mice show features that mimic the phenotype found in humans. Furthermore, the possible use of Xpa- and other nucleotide excision repair deficient mice in cancer research will be outlined in more detail.
Insights
Xeroderma pigmentosum group A (XPA) protein deficiency impairs DNA repair, leading to cancer. XPA-deficient mice mimic human disease, offering a model for cancer research.
Area of Science:
- Molecular Biology
- Genetics
- Cancer Research
Background:
- The xeroderma pigmentosum group A (XPA) gene encodes a DNA-binding protein crucial for recognizing DNA damage.
- Nucleotide excision repair (NER) is a key pathway defending cells against UV-B and chemical mutagens.
- Defects in NER disrupt cellular processes, increasing mutation accumulation and cancer risk.
Purpose of the Study:
- To investigate the role of XPA in DNA repair and its implications for cancer.
- To characterize XPA-deficient transgenic mice as a model for human xeroderma pigmentosum.
- To explore the utility of NER-deficient mice in cancer research.
Main Methods:
- Gene sequencing and protein analysis to understand XPA function.
- Development and characterization of XPA-deficient transgenic mouse models.
- Phenotypic analysis of XPA-deficient mice, including cancer development.
Main Results:
- XPA protein is essential for the initial recognition of DNA damage in nucleotide excision repair.
- XPA-deficient mice exhibit phenotypes mirroring human xeroderma pigmentosum, including increased skin cancer susceptibility.
- These mice serve as a valuable preclinical model for studying DNA repairdeficiency-related cancers.
Conclusions:
- XPA plays a critical role in maintaining genomic stability through DNA repair.
- XPA-deficient mice provide a relevant model for understanding xeroderma pigmentosum and developing cancer therapies.
- NER-deficient mouse models are instrumental for advancing cancer research and therapeutic strategies.